Alzheimer's disease (AD), a major cause of morbidity and mortality, is caused at least in part by the toxicity of Abeta, a proteolytic product of a receptor-like protein called amyolid-beta precursor protein (APP). Although much progress was made in the understanding of how APP cleavage generates Abeta, the normal functions of APP, the relation of these functions to Abeta production and AD pathogenesis, and the mechanism by which Abeta damages neurons are incompletely understood. Recent studies suggest that AD is initially a disease of synapses, and that the characteristic cognitive impairment of early AD is due to a loss of synapse function. AD may affect synapses because synapses are exquisitely sensitive to injury, and/or because the function of APP acts directly or indirectly on synapses. The overall goal of the current application is to follow up on this hypothesis by utilizing the tools and reagents that our laboratory has developed to analyse synapse function.
We aim to characterize the possible physiological role of APP at the synapse, and to examine how the synaptic etiology of AD is related to this physiological role. Since diverse functions have been associated with APP and a variety of mechanisms have been invoked in the pathogenesis of AD, this application proposes a wide spectrum of approaches ranging from cell biology and biochemical protein purification to genetic experiments in mice. These experiments will investigate the functions of APP, and relate these functions to the production and pathogenicity of Abeta. Specifically, we propose to identify and functionally characterize extracellular ligands for APP as a first approach to understanding the function of the conserved extracellular sequences of APP (specific aim 1), a goal that was already partially achieved in preliminary results with the isolation of specific APP ligands. We also propose to test the possible role of APP as a transcriptional regulator (specific aim 2), a role that we recently identified in transactivation experiments, and to analyze the functions of Mints, which bind to APP (specific aim 3). Furthermore, we propose to examine the relation of APP cleavage and Abeta production to intracellular membrane traffic and its regulation, and to test the physiological significance of APP cleavage (specific aim 4). Finally, we propose to clarify the question whether Abeta exerts a specifically synaptic toxicity, and to investigate the mechanism of its toxicity by using novel mouse models of AD that allow a more mechanistic approach than currently available models (specific aim 5). Together these studies will contribute to our understanding of APP function and Abeta toxicity in AD, and may suggest new avenues for interfering with the pathogenesis of AD.

National Institute of Health (NIH)
National Institute of Mental Health (NIMH)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-MDCN-3 (02))
Program Officer
Asanuma, Chiiko
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
Schools of Medicine
United States
Zip Code
Zhang, Zhenjie; Marro, Samuele G; Zhang, Yingsha et al. (2018) The fragile X mutation impairs homeostatic plasticity in human neurons by blocking synaptic retinoic acid signaling. Sci Transl Med 10:
S├╝dhof, Thomas C (2018) Towards an Understanding of Synapse Formation. Neuron 100:276-293
Ho, Angela; Liu, Xinran; Sudhof, Thomas C (2008) Deletion of Mint proteins decreases amyloid production in transgenic mouse models of Alzheimer's disease. J Neurosci 28:14392-400
Gallardo, Gilbert; Schluter, Oliver M; Sudhof, Thomas C (2008) A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides. Nat Neurosci 11:301-8
Khvotchev, Mikhail; Dulubova, Irina; Sun, Jianyuan et al. (2007) Dual modes of Munc18-1/SNARE interactions are coupled by functionally critical binding to syntaxin-1 N terminus. J Neurosci 27:12147-55
Chubykin, Alexander A; Atasoy, Deniz; Etherton, Mark R et al. (2007) Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Neuron 54:919-31
Cao, Xinwei; Sudhof, Thomas C (2004) Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation. J Biol Chem 279:24601-11
Dulubova, Irina; Ho, Angela; Huryeva, Iryna et al. (2004) Three-dimensional structure of an independently folded extracellular domain of human amyloid-beta precursor protein. Biochemistry 43:9583-8
Li, Qiming; Sudhof, Thomas C (2004) Cleavage of amyloid-beta precursor protein and amyloid-beta precursor-like protein by BACE 1. J Biol Chem 279:10542-50